Virology News
63.7K views | +1 today
Follow
 
Scooped by Ed Rybicki
onto Virology News
Scoop.it!

Patenting viruses doesn't restrict research--it gives an incentive to do more research.

Patenting viruses doesn't restrict research--it gives an incentive to do more research. | Virology News | Scoop.it

In June, the U.S. Supreme Court ruled that people can’t patent isolated human genes, which it considers a product of nature, but they can patent something exceptionally similar: cDNA, a synthesized copy from which someone has removed the noncoding parts. Given that fine line, it’s not entirely clear how the decision will play out in practice or how it will affect work on nonhuman genes. But it’s a hot area of debate.

Earlier this year, Dutch scientists received a patent from their country on the newly discovered MERS virus that killed at least 30 people. The researchers had isolated the virus in their laboratory from a sample sent by a Saudi doctor. The Saudi Ministry of Health protested that the patent would restrict research and lead to more deaths; the World Health Organization (WHO) said it would investigate the legality and take action. But they’ve got it backward. Patents are one of the best tools for quickly fighting disease.

Ed Rybickis insight:

Definitely!  I hate to say it out loud, in this era of "openness", but if you DON'T patent things sometimes, you may well have messed up the use of it for ever - because no-one commercial will touch anything that isn't protected / protectable.

Which means that funky new vaccine you just published on without protecting it will be forever "an interesting paper", but never a product.

The NIH labs, for example, patent everything novel that passes through - because then they have a say in how it is commercialised, and can stop it being blocked by some company that wants to keep its own proprietary product current for that much longer.

Our lab has quite a big patent portfolio, for example: we have something like 14 patent families, and over 60 individual country patents, which gives us a reasonable stock-in-trade when it comes to licencing things to companies.  It has also given us leverage in getting money to work on new / improved versions of vaccines, for example, which has helped keep the lab afloat for a goodly number of years now!

We also negotiated rights to licencing / commercialisation for certain things, such as guarantees for low pricing for South Africa and Africa, keeping all rights for Africa and sharing rights elsewhere, and so on.

So they can be a tool for good, as well as all the other things they are accused of being!

 

Thanks, Arvind Varsani, for alerting me to this.

No comment yet.
Virology News
Topical news snippets about viruses that affect people.  And other things. Like Led Zeppelin. And zombies B-)
Curated by Ed Rybicki
Your new post is loading...
Your new post is loading...
Scooped by Ed Rybicki
Scoop.it!

PDB-101: Goodsell Gallery: Coronavirus Life Cycle

PDB-101: Goodsell Gallery: Coronavirus Life Cycle | Virology News | Scoop.it

This illustration shows a cross section through a cell infected with a coronavirus such as SARS-CoV-2. It shows a time point when the virus is actively replicating, and new viruses are being created. The cell’s molecules are shown in blues and greens, and the viral molecules are shown in pinks and purples. The illustration integrates the current state of knowledge, but many aspects of the virus and its life cycle are still actively being studied, so portions of the painting are speculative. Additional resources for exploring coronavirus are available at PDB-101 and the main RCSB PDB site.


Ed Rybickis insight:
Share your insight
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Coronavirus killed three times as many people as flu and pneumonia combined, figures show | UK News

Coronavirus killed three times as many people as flu and pneumonia combined, figures show | UK News | Virology News | Scoop.it
The mortality rate for COVID-19 is also "significantly higher" than for flu and pneumonia this year.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Russia likely to register a second COVID-19 vaccine on October 15

Russia likely to register a second COVID-19 vaccine on October 15 | Virology News | Scoop.it
The vaccine has been developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last month.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19. | bi...

bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Poultry farmers and pet bird keepers urged to prepare for winter avian flu

Poultry farmers and pet bird keepers urged to prepare for winter avian flu | Virology News | Scoop.it
Poultry keepers are urged to prepare for winter avian flu and reduce the risk of disease in their birds over the winter...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Andrew Wakefield's fraudulent war on vaccines

Andrew Wakefield's fraudulent war on vaccines | Virology News | Scoop.it
Described by the New York Times as "one of the most reviled doctors of his generation", Andrew Wakefield, known for his false claims of a causative connection between the MMR vaccine and autism, was struck off following a hearing of the General Medical Council in 2003.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India

Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India | Virology News | Scoop.it
NVAX Novavax Inc Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax’ Global Produc...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Modeling the Worldwide Spread of Pandemic Influenza: Baseline Case and Containment Interventions

Modeling the Worldwide Spread of Pandemic Influenza: Baseline Case and Containment Interventions | Virology News | Scoop.it
A metapopulation stochastic epidemic model for influenza shows the need to include air transportation when assessing the occurrence probability of global outbreaks. The impact of the use of antiviral drugs is also measured.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

In coronavirus vaccine race, China inoculates thousands before trials are completed | Reuters

In coronavirus vaccine race, China inoculates thousands before trials are completed | Reuters | Virology News | Scoop.it
China is inoculating tens of thousands of its citizens with experimental coronavirus vaccines and attracting international interest in their development, despite expert concerns over the safety of drugs that have not completed standard testing.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Coronavirus vaccine may be ready for public November – China

Coronavirus vaccine may be ready for public November – China | Virology News | Scoop.it
An official the Chinese Centre for Disease Control and Prevention, Guizhen Wu, has said the coronavirus vaccines being developed in China may be ready...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Why the Mutation That Made SARS-CoV-2 More Infective Isn't That Big a Deal

Why the Mutation That Made SARS-CoV-2 More Infective Isn't That Big a Deal | Virology News | Scoop.it
The chances that a vaccine will not work due to a single amino acid changing is very, very, very low.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Louis Vuitton designed a luxury face shield selling for nearly $1K

Louis Vuitton designed a luxury face shield selling for nearly $1K | Virology News | Scoop.it
Louis Vuitton designed a luxury face shield selling for nearly $1K...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Flu Season Disappeared in the Southern Hemisphere This Year –

Flu Season Disappeared in the Southern Hemisphere This Year – | Virology News | Scoop.it
Ever since we all started wearing masks and social distancing because of COVID-19 I’ve been wondering whether this would have an effect on other illnesses. Will we have fewer colds? Less flu? It seems like we should.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Aerosol transmission of SARS-CoV-2? Evidence, prevention and control 

As public health teams respond to the pandemic of coronavirus disease 2019 (COVID-19), containment and understanding of the modes of severe acute resp…...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

'Brain fog': the people struggling to think clearly months after Covid | World news | The Guardian

'Brain fog': the people struggling to think clearly months after Covid | World news | The Guardian | Virology News | Scoop.it
Doctors grapple for answers as more patients report post-coronavirus cognitive impairment...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

'Near extinction' of influenza in NZ as numbers drop due to lockdown

'Near extinction' of influenza in NZ as numbers drop due to lockdown | Virology News | Scoop.it
Mask wearing and social distancing for Covid-19 has all but cut influenza cases in New Zealand this year, with only six flu isolates detected in this country from April to August.  Professor Michael Baker offers his analysis.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Coronavirus can last 28 days on glass, currency, study finds | Inquirer News

Coronavirus can last 28 days on glass, currency, study finds | Inquirer News | Virology News | Scoop.it
The virus that causes COVID-19 can survive on banknotes, glass and stainless steel for up to 28 days, much longer than the flu virus, Australian researchers said on Monday, highlighting the need for cleaning and hand-washing to combat the virus.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

What counts as a 'superspreader' event?

What counts as a 'superspreader' event? | Virology News | Scoop.it
Face-to-face gatherings up the chance for COVID-19's spread, but which events are "superspreaders" and how can we prevent them? An expert explains.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Vaccine maker warns it could take until 2024 to vaccinate everyone against Covid-19

The world's largest vaccine maker, Serum Institute, says it may take until 2024 to get everyone a Covid-19 vaccine if the vaccine requires two doses. CNN's Athena Jones reports.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen | BusinessWorld

Flu outbreaks may be linked to COVID-19; arthritis drug benefit seen | BusinessWorld | Virology News | Scoop.it

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Flu may be linked with coronavirus spread Influenza outbreaks may be linked with the spread of COVID-19 infections, according to a European study. The researchers created a mathematical model of transmission of the novel coronavirus in Belgium, Italy, Norway and Spain. It calculates that higher rates of influenza infections would be associated with increased coronavirus transmission in each of the countries

No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Strict distancing keeps your COVID risk much lower

Strict distancing keeps your COVID risk much lower | Virology News | Scoop.it
"Our findings support the idea that if you're going out, you should practice social distancing to the extent possible..."...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Russia to Supply 100M Doses of Sputnik V Vaccine to Dr Reddy’s

Russia to Supply 100M Doses of Sputnik V Vaccine to Dr Reddy’s | Virology News | Scoop.it
Sputnik V, an adenovirus vector-based vaccine, was developed by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, along with the Russian Direct Investment Fund and registered on 11 August.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Sinovac reports preliminary Phase I/II results of COVID-19 vaccine in elderly volunteers

Sinovac Biotech Ltd.(NASDAQ: SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China...
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans

A role for gorilla APOBEC3G in shaping lentivirus evolution including transmission to humans | Virology News | Scoop.it
Author summary Humans are exposed continuously to a menace of viral diseases such as Ebola virus and coronaviruses. Such emerging/re-emerging viral outbreaks can be triggered by cross-species viral transmission from wild animals to humans.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

Table: Viruses that Threaten to Spark Another Pandemic

Table: Viruses that Threaten to Spark Another Pandemic | Virology News | Scoop.it
A coronavirus has been commanding the headlines for months, but strains of influenza and paramyxovirus are extremely dangerous pathogens that could spark outbreaks.
No comment yet.
Scooped by Ed Rybicki
Scoop.it!

AstraZeneca COVID vaccine trials resume after being put on hold

AstraZeneca COVID vaccine trials resume after being put on hold | Virology News | Scoop.it
Phase three clinical trials resumed after pausing to review safety data. Around 18,000 people have received the vaccine, which is being developed in partnership with the University of Oxford.
No comment yet.